ALDH2 and esophageal squamous cell carcinoma: In this study, we hypothesized that the ABT, which accurately identifies ALDH2 inactivity noninvasively as a disease marker for superficial ESCC and superficial HPSCC treated with ESD, would exhibit clinical significance and usefulness.